|
|
|
| home > white papers > Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor - Eppendorf |
|
|
 WHITE PAPERS |
|
Eppendorf
|
|
Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor
|
|
The number of bioprocess applications for microalgae has increased in
recent years, particularly in the fi eld of biofuel production. The
combination of the New Brunswick CelliGen 310 stirred-tank bioreactor
and the DASGIP LED Illumination System creates a bioreactor setup which
is capable of supporting high density microalgal growth. Using the
stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and
intensities can be controlled for optimal support of all types of
chlorophylls and carotenoids. For this study in which high density
culture of up to 1.5 x 107 cells/mL was achieved, the unicellular
freshwater alga, Dunaliella tertiolecta, was used.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
MedPharm Expands Relationship With Novan On Formulation Science
MedPharm Ltd, a leader in topical and transdermal drug delivery, has
expanded its relationship with the NASDAQ listed biopharmaceutical
company Novan Inc.
MedPharm has previously supported Novan by testing the company’s unique
formulations using its proprietary in vitro models to optimise Novan’s
formulations and de-risk product development.
More info >> |
|
 |
White Papers |
 |
|
Orthogonal Approaches for the Analysis of Protein Sequence
Ludger Ltd
One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >> |
|
 |
Industry Events |
 |
2020 Avoca Quality and Innovation Summit
3-4 June 2020, Amsterdam, The Netherlands
The 2020 Avoca Quality and Innovation Summit will take place 3-4 June
2020, in Amsterdam, The Netherlands.
More info >> |
|
|
|
